Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
MPH Health Care AG, established in 2008 and headquartered in Berlin, Germany, is an investment holding company focusing on the acquisition, development, and sale of companies within the healthcare sector, particularly in areas such as chronic diseases, medical aesthetic treatments, and healthcare digitalization. Its portfolio includes M1 Kliniken AG, specializing in aesthetic and plastic medical services; HAEMATO AG, a pharmaceutical company concentrating on off-patent and patent-protected drugs; and CR Capital AG, involved in real estate development. MPH Health Care AG's strategic approach emphasizes long-term value creation through active development of its investments, aiming to provide cost-effective services and products of high quality.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
MPH Health Care AGJohnson & Johnson
Last price
€30.65$283.52
Currency
EUR
USD
€127M$675B
2.6442.59
€11.31$6.58
1.100.21
€5.00$5.28
16.72%1.91%
Sector
HealthHealth
Employees
2138,200
Ticker
€93M1$JNJ
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €93M1 or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.